Tag: Drug Import

Results of FAS Head and Association of European Businesses’ Members Meeting

The Working Groups will help solve particular competition issues. A traditional meeting of Head of FAS, Igor Artemiev, with representatives of the Association of European Businesses focused on the ...

FDA Examining Programs for Overseeing Global Operations and International Affairs

fda
Concerns about the quality and safety of the growing volume of medicines imported to the United States, pressure to set international policies for genome editing of other scientific developments and e...

Cooperation of Russia and Bangladesh

Russian Ambassador to Bangladesh Alexander Ignatov on Wednesday said Russian private sector is interested to invest in joint venture (JV) projects in Bangladesh. During his meeting with Foreign Min...

Vietnamese Pharma Opens for Import

It is now easier for foreign companies to join the Vietnamese pharmaceutical market, buoyed by recently-loosened business conditions regarding drug registration and imports. The Ministry of Health ...

EAEU opens pharma market for foreign manufacturers

eec
Prospective entry into the market of the EAEU of foreign medicinal products registered according to the national procedures of the EAEU States were discussed by the Member of the Board.

The import of finished medicines to Russia exceeded 244 billion rubles in H1 2018

pharma
Year over year growth comparing to the same period in 2017 when calculating in rubles amounted to 2% for finished forms, the supply of bulk products increased by 22% for the year.

Import of pharma products to Azerbaijan increased by 36%

pills
The import of pharmaceutical products to Azerbaijan in January-July 2018 amounted to $ 153 million 793.16 thousand in monetary terms, the State Customs Committee reported.

Russia increased imports of pharma products from non-CIS countries by 3.2%

Import-Export
In January-July 2018, Russia increased imports of goods from foreign countries by 11.9% to reach $ 120.67 billion, informed TASS with reference to the Federal Customs Service of Russia.

In January-May of this year, Russia imported medicines for 198.7 billion rubles

drugs
For the period January-May 2018, imports of finished dosage forms (FDF) to Russia amounted to 198.7 billion rubles (in prices of release for free circulation).

In Q1 2018 Russian imports of finished drugs fell by 7.9% in physical terms

tablets
During the first four months of 2018, the imports of finished medicinal products to Russia amounted to 156.1 billion rubles (in prices set for release for free circulation).

Imports of Kazakh medicines to Russia jumped 12.6 times since the start of 2018

kelun-kazakhstan
In January-April 2018, the imports of medicinal products manufactured in EAEU member states amounted to 3.7 billion rubles (in wholesale prices, including VAT).

Sanctions will not be imposed on medicines that are not manufactured in Russia

manturov
Counter-sanctions against the United States should not affect the medicines that are not manufactured in Russia, said the acting Russian Minister of Industry Denis Manturov.

Germany, France and Italy are leading exporters of pharma products to Russia

drugs
In 2017, Russian imports of pharmaceutical products reached $10.8 billion, which is 22% more than in the previous year.

Imports of veterinary APIs to Russia declined by 2% in January 2018

veterinary vaccine
January 2018 was marked by extremely uneven trends in supplies of veterinary products. Over the year, the supply of feed additives decreased by 13%, while the imports of veterinary drugs showed small, but positive growth.

Drug imports to Russia demonstrate a record low dynamics

pills
In January 2018, Russia imported finished medicinal products in the total amount of 30.6 billion rubles (in prices set for release for free circulation). In-bulk supplies for the same period amounted to 6.5 billion rubles.

Russia offers to open a “green channel” for Japanese pharmaceutical companies

rus-japan
Russia proposed to open so-called “green channel” for Japanese pharmaceutical and medical device companies. This was announced by the Russian Deputy Prime Minister Olga Golodets.